Michael Barbella, Managing Editor06.01.24
Materials and artificial intelligence were ODT website fan favorites this post-holiday week.
A magazine feature exploring orthopedic material design and the technological advancements in material composition landed in the top five most-read stories, as did a print column explaining the benefits of additive manufacturing (AM) for contract manufacturers. By incorporating AM alongside traditional manufacturing technologies, the column states, contract manufacturers can expand their product portfolios, curb rising tooling costs and shorten long lead times. "By integrating AM into a historically traditional manufacturing workflow, contract manufacturers have the potential to strengthen and expand relationships with current customers, as well as grow their customer base" Aaron Schmitz and John Ruggieri, (3D Systems and ARCH Medical Solutions, respectively), state in their column.
Topping the week's popularity contest, however, was the FDA's decision to award breakthrough device status to Medtronic's Infuse bone graft with an intervertebral fusion device and commercially available metallic screw and rod system. The designation specifically pertains to using Infuse in a transforaminal lumbar interbody fusion (TLIF) approach at one or two adjacent levels from L2-S1 to treat degenerative disease of the lumbosacral spine.
Visitors curious about artificial intelligence gravitated toward a news item about the technology's potential to assess and treat fractures. A study published in the Journal of Orthopaedic Research uncovered a significant association between hospital readmission rates after fracture surgery and underlying medical conditions. Investigators also found correlations between underlying medical conditions and orthopedic complications, although these links were not significant.
A magazine feature exploring orthopedic material design and the technological advancements in material composition landed in the top five most-read stories, as did a print column explaining the benefits of additive manufacturing (AM) for contract manufacturers. By incorporating AM alongside traditional manufacturing technologies, the column states, contract manufacturers can expand their product portfolios, curb rising tooling costs and shorten long lead times. "By integrating AM into a historically traditional manufacturing workflow, contract manufacturers have the potential to strengthen and expand relationships with current customers, as well as grow their customer base" Aaron Schmitz and John Ruggieri, (3D Systems and ARCH Medical Solutions, respectively), state in their column.
Topping the week's popularity contest, however, was the FDA's decision to award breakthrough device status to Medtronic's Infuse bone graft with an intervertebral fusion device and commercially available metallic screw and rod system. The designation specifically pertains to using Infuse in a transforaminal lumbar interbody fusion (TLIF) approach at one or two adjacent levels from L2-S1 to treat degenerative disease of the lumbosacral spine.
Visitors curious about artificial intelligence gravitated toward a news item about the technology's potential to assess and treat fractures. A study published in the Journal of Orthopaedic Research uncovered a significant association between hospital readmission rates after fracture surgery and underlying medical conditions. Investigators also found correlations between underlying medical conditions and orthopedic complications, although these links were not significant.